![]() ![]() As such, it is preferable to underestimate a patient’s 2. Fentanyl Transdermal system when serum concentrations from the initial patch will peak. Monitor patients closely for respiratory depression, especially within the first 2. Initiate the dosing regimen for each patient individually, taking into account the patient's prior analgesic treatment experience and risk factors for addiction, abuse, and misuse. Patients considered opioid- tolerant are those who are taking at least 6. As Fentanyl Transdermal system is only for use in opioid- tolerant patients, do not begin any patient on Fentanyl Transdermal system as the first opioid. Discontinue or taper all other extended- release opioids when beginning Fentanyl Transdermal system therapy. Due to the risk of respiratory depression, Fentanyl Transdermal system is only indicated for use in patients who are already opioid- tolerant. Fentanyl Transdermal system should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain. Fentanyl Transdermal Dosage and Administration. Limitations of Use.īecause of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended- release opioid formulations, reserve Fentanyl Transdermal system for use in patients for whom alternative treatment options (e. ![]() Patients considered opioid- tolerant are those who are taking, for one week or longer, at least 6. Fentanyl Transdermal system is indicated for the management of pain in opioid- tolerant patients, severe enough to require daily, around- the- clock, long- term opioid treatment and for which alternative treatment options are inadequate. Fentanyl Transdermal - FDA prescribing information, side effects and uses. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2023
Categories |